Publications

This document contains the recommendations made at the Ministerial Advisory Committee on Blood Borne Viruses and Sexually Transmissible Infections (MACBBVSTI) Hepatitis B roundtable on 19 March 2021.

Six month schedule point.

4 month schedule point.

2 month schedule point.

AusVaxSafety is a national system monitoring vaccine safety in Australia. The report shows how people receiving vaccines, or their parents and carers, responded to the SMS about their health a few days after vaccination at each schedule point in the National Immunisation Program in Australia 2019.

AusVaxSafety is a national system for monitoring vaccine safety in Australia. This infographic provides a visual representation of the number of parents and carers who responded to an SMS about their child’s health a few days after their 6 month vaccinations.

AusVaxSafety is a national system for monitoring vaccine safety in Australia. This infographic provides a visual representation of the number of parents and carers who responded to an SMS about their child’s health a few days after their 4 month vaccinations.

AusVaxSafety is a national system for monitoring vaccine safety in Australia. This infographic provides a visual representation of the number of parents and carers who responded to an SMS about their child’s health a few days after their 2 month vaccinations.

These guidelines from the Communicable Diseases Network Australia (CDNA) contain the current expert consensus on the evidence for health care workers and their blood borne virus status.

Research reports on qualitative and quantitative research conducted on attitudes and behaviours regarding childhood and adult immunisation:

This brochure includes information about the benefits of childhood vaccination. Get the facts about how immunisation saves lives.

This poster aims to remind parents to immunise their children on time to protect them and the community from diseases.

This resource provides Australian Technical Advisory Group on Immunisation (ATAGI) clinical advice regarding the use of alternative vaccines during periods when adult formulations of hepatitis B vaccines are not available.